SubQ Herceptin Equivalent to IV Delivery (CME/CE)
09:20 EDT 10 Aug 2012 | MedPageToday
(MedPage Today) -- A subcutaneous form of trastuzumab demonstrated activity and pharmacokinetics comparable to intravenous administration in breast cancer patients who received the agent before surgery, trial results showed.
Original Article: SubQ Herceptin Equivalent to IV Delivery (CME/CE)
More From BioPortfolio on "SubQ Herceptin Equivalent to IV Delivery (CME/CE)"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
